Literature DB >> 20535801

Yellow fever revaccination during infliximab therapy.

Morton Scheinberg1, Luis Sergio Guedes-Barbosa, Cristovao Mangueira, Eliane Aparecida Rosseto, Licia Mota, Ana Cristina Oliveira, Rodrigo Aires Lima.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20535801     DOI： 10.1002/acr.20045

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN： 2151-464X            Impact factor:   4.794


× No keyword cloud information.
  13 in total

1.  TNF-α Antagonists and Immunization.

Authors:  Leo G Visser
Journal:  Curr Infect Dis Rep       Date:  2011-06       Impact factor: 3.725

2.  Association between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.

Authors:  Jie Zhang; Fenglong Xie; Elizabeth Delzell; Lang Chen; Kevin L Winthrop; James D Lewis; Kenneth G Saag; John W Baddley; Jeffrey R Curtis
Journal:  JAMA       Date:  2012-07-04       Impact factor: 56.272

3.  Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations.

Authors:  Marc H Jansen; Christien Rondaan; Geertje Legger; Kirsten Minden; Yosef Uziel; Nataša Toplak; Despoina Maritsi; Mirjam van den Berg; Guy Berbers; Patricia Bruijning; Yona Egert; Christophe Normand; Marc Bijl; Helen Foster; Isabelle Kone-Paut; Carine Wouters; Angelo Ravelli; Ori Elkayam; Nicolaas M Wulffraat; Marloes W Heijstek
Journal:  Front Pediatr       Date:  2022-07-06       Impact factor: 3.569

4.  Inadvertent yellow fever vaccination of a patient with Crohn's disease treated with infliximab and methotrexate.

Authors:  Christina Ekenberg; Nina Friis-Møller; Thomas Ulstrup; Claus Aalykke
Journal:  BMJ Case Rep       Date:  2016-08-29

5.  The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.

Authors:  Jie Zhang; Elizabeth Delzell; Fenglong Xie; John W Baddley; Claire Spettell; Raechele M McMahan; Joaquim Fernandes; Lang Chen; Kevin Winthrop; Jeffrey R Curtis
Journal:  Arthritis Res Ther       Date:  2011-10-24       Impact factor: 5.156

Review 6.  Vaccinations in paediatric rheumatology: an update on current developments.

Authors:  Noortje Groot; Marloes W Heijstek; Nico M Wulffraat
Journal:  Curr Rheumatol Rep       Date:  2015-07       Impact factor: 4.592

Review 7.  Effects of biological and non-biological immunomodulatory therapies on the immunogenicity of vaccines in patients with rheumatic diseases.

Authors:  Zsuzsanna H McMahan; Clifton O Bingham
Journal:  Arthritis Res Ther       Date:  2014-12-23       Impact factor: 5.156

Review 8.  Yellow fever vaccine and risk of developing serious adverse events: a systematic review.

Authors:  Ruben Porudominsky; Eduardo H Gotuzzo
Journal:  Rev Panam Salud Publica       Date:  2018-06-05

9.  Vaccination Guidelines for Patients With Immune-Mediated Disorders on Immunosuppressive Therapies.

Authors:  Kim A Papp; Boulos Haraoui; Deepali Kumar; John K Marshall; Robert Bissonnette; Alain Bitton; Brian Bressler; Melinda Gooderham; Vincent Ho; Shahin Jamal; Janet E Pope; A Hillary Steinhart; Donald C Vinh; John Wade
Journal:  J Cutan Med Surg       Date:  2018-11-21       Impact factor: 2.092

10.  Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations.

Authors:  Christien Rondaan; Victoria Furer; Marloes W Heijstek; Nancy Agmon-Levin; Marc Bijl; Ferdinand C Breedveld; Raffaele D'Amelio; Maxime Dougados; Meliha C Kapetanovic; Jacob M van Laar; Annette Ladefoged de Thurah; Robert Landewé; Anna Molto; Ulf Müller-Ladner; Karen Schreiber; Leo Smolar; Jim Walker; Klaus Warnatz; Nico M Wulffraat; Sander van Assen; Ori Elkayam
Journal:  RMD Open       Date:  2019-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.